Charles John Billington
#162,061
Most Influential Person Now
Charles John Billington's AcademicInfluence.com Rankings
Charles John Billingtonbiology Degrees
Biology
#12893
World Rank
#16398
Historical Rank
Endocrinology
#197
World Rank
#210
Historical Rank
Neuroscience
#2198
World Rank
#2259
Historical Rank
Download Badge
Biology
Charles John Billington's Degrees
- Bachelors Biology University of California, Berkeley
Similar Degrees You Can Earn
Why Is Charles John Billington Influential?
(Suggest an Edit or Addition)Charles John Billington's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Orexin activation counteracts decreases in nonexercise activity thermogenesis (NEAT) caused by high-fat diet (2017) (1003)
- Overweight, obesity, and health risk. (2000) (945)
- Weight bias among health professionals specializing in obesity. (2003) (811)
- Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. (2013) (658)
- Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism. (1991) (445)
- Effect of Protein Ingestion on the Glucose and Insulin Response to a Standardized Oral Glucose Load (1984) (443)
- Feeding response to central orexins (1999) (325)
- Neuropeptide Y in hypothalamic paraventricular nucleus: a center coordinating energy metabolism. (1994) (325)
- Obesity as a Disease: A White Paper on Evidence and Arguments Commissioned by the Council of The Obesity Society (2008) (282)
- The lighter side of BDNF. (2011) (262)
- Orphanin FQ, agonist of orphan opioid receptor ORL1, stimulates feeding in rats (1996) (206)
- Opioids and food intake: distributed functional neural pathways? (1999) (204)
- Lifestyle Intervention and Medical Management With vs Without Roux-en-Y Gastric Bypass and Control of Hemoglobin A1c, LDL Cholesterol, and Systolic Blood Pressure at 5 Years in the Diabetes Surgery Study (2018) (200)
- Feeding effects of hypothalamic injection of melanocortin 4 receptor ligands (1998) (190)
- Opioids and consummatory behavior (1985) (188)
- Effect of reversible intermittent intra-abdominal vagal nerve blockade on morbid obesity: the ReCharge randomized clinical trial. (2014) (183)
- Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial. (2015) (167)
- Intra-abdominal vagal blocking (VBLOC therapy): clinical results with a new implantable medical device. (2008) (163)
- The EMPOWER Study: Randomized, Prospective, Double-Blind, Multicenter Trial of Vagal Blockade to Induce Weight Loss in Morbid Obesity (2012) (158)
- Palatability-induced hyperphagia increases hypothalamic Dynorphin peptide and mRNA levels (1996) (151)
- Dieting and the development of eating disorders in overweight and obese adults. (2000) (150)
- Opioids as agents of reward-related feeding: a consideration of the evidence (2004) (138)
- Neural basis of orexigenic effects of ghrelin acting within lateral hypothalamus (2003) (135)
- Naloxone blocks that portion of feeding driven by sweet taste in food-restricted rats. (1995) (130)
- Preference and diet type affect macronutrient selection after morphine, NPY, norepinephrine, and deprivation. (1994) (119)
- Bone morphogenic protein 2 directly enhances differentiation of murine osteoclast precursors (2010) (117)
- Hypothalamic paraventricular injections of ghrelin: effect on feeding and c-Fos immunoreactivity (2003) (116)
- Two-Year Outcomes of Vagal Nerve Blocking (vBloc) for the Treatment of Obesity in the ReCharge Trial (2016) (109)
- Naloxone's anorectic effect is dependant upon the relative palatability of food (1993) (108)
- Evaluation of a Quantitative Magnetic Resonance Imaging System for Whole Body Composition Analysis in Rodents (2010) (107)
- Brain-derived neurotrophic factor in the ventromedial nucleus of the hypothalamus reduces energy intake. (2007) (106)
- Effect of CART in the hypothalamic paraventricular nucleus on feeding and uncoupling protein gene expression (2000) (106)
- Chronic food restriction and acute food deprivation decrease mRNA levels of opioid peptides in arcuate nucleus. (1996) (102)
- Exenatide as a Weight‐Loss Therapy in Extreme Pediatric Obesity: A Randomized, Controlled Pilot Study (2012) (100)
- Opioids Are They Regulators of Feeding? a (1989) (100)
- Why do we eat? A neural systems approach. (1997) (99)
- Potency of naloxone's anorectic effect in rats is dependent on diet preference. (1996) (99)
- Brain-derived neurotrophic factor in the hypothalamic paraventricular nucleus increases energy expenditure by elevating metabolic rate. (2007) (97)
- Naltrexone administered to central nucleus of amygdala or PVN: neural dissociation of diet and energy. (2000) (97)
- Brain-derived neurotrophic factor (BDNF) in the hypothalamic ventromedial nucleus increases energy expenditure (2010) (95)
- Rat hypothalamic NPY mRNA and brown fat uncoupling protein mRNA after high-carbohydrate or high-fat diets. (1994) (94)
- Sleep disorders, obesity, and aging: The role of orexin (2015) (93)
- Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: a preliminary study. (2007) (92)
- FGF 19 and Bile Acids Increase Following Roux-en-Y Gastric Bypass but Not After Medical Management in Patients with Type 2 Diabetes (2016) (91)
- Effects of opioid antagonists naloxone and naltrexone on neuropeptide Y-induced feeding and brown fat thermogenesis in the rat. Neural site of action. (1995) (90)
- Brain-derived neurotrophic factor in the hypothalamic paraventricular nucleus reduces energy intake. (2007) (88)
- Nor-binaltorphimine decreases deprivation and opioid-induced feeding (1990) (88)
- Neuroregulation of nonexercise activity thermogenesis and obesity resistance. (2008) (87)
- Effects of the opioid antagonist naltrexone on feeding induced by DAMGO in the central nucleus of the amygdala and in the paraventricular nucleus in the rat (1998) (87)
- Paraventricular opioids alter intake of high-fat but not high-sucrose diet depending on diet preference in a binge model of feeding. (2007) (86)
- Effects of the opioid antagonist naltrexone on feeding induced by DAMGO in the ventral tegmental area and in the nucleus accumbens shell region in the rat. (2003) (85)
- Are peptides truly satiety agents? A method of testing for neurohumoral satiety effects. (1983) (83)
- Opioids in the nucleus of the solitary tract are involved in feeding in the rat. (1997) (83)
- Effect of breakfast cereals on short-term food intake. (1989) (83)
- Drosophila Target of Rapamycin Kinase Functions as a Multimer (2006) (82)
- Roux-enY Gastric Bypass vs Intensive Medical Management for theControlofType 2 Diabetes , Hypertension , and Hyperlipidemia The Diabetes Surgery Study Randomized Clinical Trial (2013) (81)
- Neuropeptidergic Mediators of Spontaneous Physical Activity and Non-Exercise Activity Thermogenesis (2007) (81)
- Alterations in food intake by opioid and dopamine signaling pathways between the ventral tegmental area and the shell of the nucleus accumbens (2004) (80)
- Association between the amygdala and nucleus of the solitary tract in μ-opioid induced feeding in the rat (1998) (79)
- STZ-induced diabetes decreases and insulin normalizes POMC mRNA in arcuate nucleus and pituitary in rats. (1999) (79)
- Durability of Addition of Roux-en-Y Gastric Bypass to Lifestyle Intervention and Medical Management in Achieving Primary Treatment Goals for Uncontrolled Type 2 Diabetes in Mild to Moderate Obesity: A Randomized Control Trial (2016) (78)
- Which Opioid Receptor Mechanism Modulates Feeding? (1984) (78)
- ARC POMC mRNA and PVN α-MSH are lower in obese relative to lean Zucker rats (2000) (77)
- Oxytocin in the ventromedial hypothalamic nucleus reduces feeding and acutely increases energy expenditure. (2014) (77)
- Interaction of the Hypothalamic Paraventricular Nucleus and Central Nucleus of the Amygdala in Naloxone Blockade of Neuropeptide Y-Induced Feeding Revealed by c-fos Expression (1997) (76)
- Brain orexin promotes obesity resistance (2012) (74)
- Vagal Blocking Improves Glycemic Control and Elevated Blood Pressure in Obese Subjects with Type 2 Diabetes Mellitus (2013) (71)
- Sustained Weight Loss with Vagal Nerve Blockade but Not with Sham: 18-Month Results of the ReCharge Trial (2015) (69)
- Sucrose consumption increases naloxone-induced c-Fos immunoreactivity in limbic forebrain. (2000) (69)
- Insulin and Glucose Responses to Various Starch-Containing Foods in Type II Diabetic Subjects (1987) (67)
- Weight and body mass index in Parkinson's disease patients after deep brain stimulation surgery. (2005) (67)
- Glucagon stimulation of brown adipose tissue growth and thermogenesis. (1987) (67)
- Divergence of the feeding and thermogenic pathways influenced by NPY in the hypothalamic PVN of the rat. (1998) (66)
- Hypocretin I in the lateral hypothalamus activates key feeding‐regulatory brain sites (2000) (66)
- Exercise reduces diet-induced cognitive decline and increases hippocampal brain-derived neurotrophic factor in CA3 neurons (2014) (66)
- Hypocretin/orexin and energy expenditure (2010) (66)
- Hypothalamic neuropeptide Y regulation of feeding and energy metabolism (1992) (65)
- Glucagon in physiological concentrations stimulates brown fat thermogenesis in vivo. (1991) (64)
- Effect of naloxone on intake of cornstarch, sucrose, and polycose diets in restricted and nonrestricted rats. (1996) (64)
- Naloxone effects on sucrose-motivated behavior (1996) (63)
- Naloxone's effects on operant responding depend upon level of deprivation (1994) (62)
- Selection of electrical algorithms to treat obesity with intermittent vagal block using an implantable medical device. (2009) (62)
- Urocortin in the hypothalamic PVN increases leptin and affects uncoupling proteins-1 and -3 in rats. (2002) (60)
- The serum insulin and plasma glucose responses to milk and fruit products in Type 2 (non-insulin-dependent) diabetic patients (1986) (60)
- The Effect of Naltrexone on Taste Detection and Recognition Threshold (1999) (59)
- Opioids affect acquisition of LiCl-induced conditioned taste aversion: involvement of OT and VP systems. (2000) (57)
- Orexin A decreases lipid peroxidation and apoptosis in a novel hypothalamic cell model (2012) (57)
- Neural site of leptin influence on neuropeptide Y signaling pathways altering feeding and uncoupling protein. (1998) (57)
- Feeding inhibition by urocortin in the rat hypothalamic paraventricular nucleus. (2001) (54)
- Role of orexin A signaling in dietary palmitic acid-activated microglial cells (2015) (54)
- Chronic administration of brain-derived neurotrophic factor in the hypothalamic paraventricular nucleus reverses obesity induced by high-fat diet. (2010) (53)
- Adipokine response in diabetics and nondiabetics following the Roux-en-Y gastric bypass: a preliminary study. (2007) (52)
- Our journey with neuropeptide Y: effects on ingestive behaviors and energy expenditure (2004) (52)
- Behavioral responses to orexin, orexin receptor gene expression, and spontaneous physical activity contribute to individual sensitivity to obesity. (2012) (52)
- The effect of centrally administered naloxone on deprivation and drug-induced feeding (1990) (52)
- The effect of norbinaltorphimine, β-funaltrexamine and naltrindole on NPY-induced feeding (1993) (52)
- Sleep and obesity: A focus on animal models (2012) (51)
- Regional effect of naltrexone in the nucleus of the solitary tract in blockade of NPY-induced feeding. (2000) (51)
- Orexin/hypocretin treatment restores hippocampal-dependent memory in orexin-deficient mice (2017) (51)
- Elevated Sleep Quality and Orexin Receptor mRNA in Obesity Resistant Rats (2010) (47)
- Neuropeptides and appetite: contribution of neuropharmacological modeling. (1984) (47)
- Medical care for obese patients: advice for health care professionals. (2002) (46)
- The kappa-opioid antagonist GNTI reduces U50,488-, DAMGO-, and deprivation-induced feeding, but not butorphanol- and neuropeptide Y-induced feeding in rats (2001) (45)
- Neuromodulation of orexin neurons reduces diet-induced adiposity (2017) (45)
- Neuropeptides controlling energy balance: orexins and neuromedins. (2012) (45)
- Spontaneous physical activity protects against fat mass gain (2011) (45)
- Fos expression in feeding-related brain areas following intracerebroventricular administration of orphanin FQ in rats (2000) (44)
- Role of α-MSH in the regulation of consummatory behavior: immunohistochemical evidence (2001) (44)
- The effect of naloxone on food-motivated behavior in the obese Zucker rat (1999) (43)
- Effect of nociceptin/orphanin FQ on food intake in rats that differ in diet preference (2002) (43)
- Effects of palatability-induced hyperphagia and food restriction on mRNA levels of neuropeptide-Y in the arcuate nucleus (1998) (42)
- Partial sleep deprivation by environmental noise increases food intake and body weight in obesity resistant rats (2012) (42)
- ß-Funaltrexamine (ß-FNA) decreases deprivation and opioid-induced feeding (1991) (42)
- The effect of peripherally administered satiety substances on feeding induced by butorphanol tartrate (1983) (42)
- Differential effects of neuropeptide Y and the μ-agonist DAMGO on `palatability' vs. `energy' (1999) (40)
- Neuroleptic Malignant Syndrome Associated with Olanzapine (1998) (40)
- Promotion of Wakefulness and Energy Expenditure by Orexin-A in the Ventrolateral Preoptic Area. (2015) (40)
- Effects of neuropeptide Y on ingestion of flavored solutions in nondeprived rats (1993) (39)
- Effect of Vagal Nerve Blockade on Moderate Obesity with an Obesity-Related Comorbid Condition: the ReCharge Study (2016) (39)
- Effect of NPY in the hypothalamic paraventricular nucleus on uncoupling proteins 1, 2, and 3 in the rat. (2000) (38)
- Intra-amygdalar injection of DAMGO: effects on c-Fos levels in brain sites associated with feeding behavior (2004) (38)
- Overweight, obesity, and associated disease burden in the Veterans Affairs ambulatory care population. (2003) (37)
- Preserved Insulin Secretory Capacity and Weight Loss Are the Predominant Predictors of Glycemic Control in Patients With Type 2 Diabetes Randomized to Roux-en-Y Gastric Bypass (2015) (37)
- Amygdalar opioids modulate hypothalamic melanocortin-induced anorexia (2009) (34)
- Twisted gastrulation limits apoptosis in the distal region of the mandibular arch in mice. (2009) (34)
- A Sucrose-Based Maintenance Diet Increases Sensitivity to Appetite Suppressant Effects of Naloxone (1997) (34)
- Naltrexone infusion inhibits the development of preference for a high-sucrose diet. (2002) (34)
- High and Low Activity Rats: Elevated intrinsic physical activity drives resistance to diet induced obesity in non-bred rats (2012) (34)
- Hyperprolactinaemia in male diabetics. (1985) (34)
- Behavioral effects of naloxone on neuropeptide Y-induced feeding (1996) (34)
- Meal replacements followed by topiramate for the treatment of adolescent severe obesity: A pilot randomized controlled trial (2016) (34)
- Mechanisms underlying obesity resistance associated with high spontaneous physical activity (2014) (33)
- Is the erythrocyte sodium pump altered in human obesity? (1983) (32)
- Thyroid function and energy intake during weight gain following treatment of hyperthyroidism. (1999) (32)
- Naloxone's effect on meal microstructure of sucrose and cornstarch diets. (2001) (32)
- Central administration of the opioid antagonist, LY255582, decreases short- and long-term food intake in rats (1991) (32)
- Lactation decreases mRNA levels of opioid peptides in the arcuate nucleus of the rat (1997) (31)
- Endorphins, immune function, and cancer. (1985) (31)
- Artifactual hypoglycemia associated with polycythemia vera. (1983) (31)
- Effects of intracerebroventricular ethanol on ingestive behavior and induction of c-Fos immunoreactivity in selected brain regions (2003) (31)
- Neuropeptides as regulators of consummatory behaviors. (1986) (31)
- Spontaneous Physical Activity Defends Against Obesity (2017) (30)
- Effects of opioid blockade with nalmefene in older impotent men. (1990) (30)
- The effect of selective opioid antagonists on butorphanol-induced feeding (1994) (29)
- Role of orexin receptors in obesity: from cellular to behavioral evidence (2013) (29)
- Orexin modulation of adipose tissue. (2014) (29)
- Feeding systems in Chinese hamsters. (1984) (28)
- Methodological considerations for measuring spontaneous physical activity in rodents. (2014) (28)
- Hypoxia induces cardiac malformations via A1 adenosine receptor activation in chicken embryos. (2008) (27)
- Orexin: Pathways to obesity resistance? (2013) (27)
- Role of carbohydrate type on diet selection in neuropeptide Y-stimulated rats. (1997) (26)
- Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia (2014) (26)
- Opioid receptor blockade in rat nucleus tractus solitarius alters amygdala dynorphin gene expression. (2002) (26)
- Role of the locus coeruleus in enhanced orexin A-induced spontaneous physical activity in obesity-resistant rats. (2013) (26)
- Naltrexone induces arcuate nucleus neuropeptide Y gene expression in the rat. (1996) (25)
- Nocistatin inhibits food intake in rats (2000) (25)
- Brown fat GDP binding and circulating metabolites during hibernation and arousal. (1989) (24)
- A review of GHRH stimulation test in psychiatry (1994) (23)
- Role of lipid type on morphine-stimulated diet selection in rats. (1999) (22)
- Role of alpha-MSH in the regulation of consummatory behavior: immunohistochemical evidence. (2001) (22)
- Effect of opioid receptor ligands injected into the rostral lateral hypothalamus on c-fos and feeding behavior (2006) (22)
- Erratum to: Intermittent Vagal Nerve Block for Improvements in Obesity, Cardiovascular Risk Factors, and Glycemic Control in Patients with Type 2 Diabetes Mellitus: 2-Year Results of the VBLOC DM2 Study (2016) (22)
- Obesity and aging. (1999) (22)
- Do circulating leptin concentrations reflect body adiposity or energy flux? (1998) (21)
- Effect of naltrexone on feeding, neuropeptide Y and uncoupling protein gene expression during lactation. (1997) (21)
- Identification of central sites involved in butorphanol-induced feeding in rats (2001) (21)
- Butorphanol increases food-reinforced operant responding in satiated rats (1994) (21)
- Effect of morphine and nalmefene on energy balance in diabetic and non-diabetic rats (1988) (20)
- Age-related changes in brain proDynorphin gene expression in the rat (2004) (20)
- Injection of alpha-MSH, but not beta-endorphin, into the PVN decreases POMC gene expression in the ARC. (2002) (20)
- Opioids, Food Reward, and Macronutrient Selection (1999) (19)
- National Differences in Remission of Type 2 Diabetes Mellitus After Roux-en-Y Gastric Bypass Surgery-Subgroup Analysis of 2-Year Results of the Diabetes Surgery Study Comparing Taiwanese with Americans with Mild Obesity (BMI 30–35 kg/m2) (2016) (19)
- Role of spontaneous physical activity in prediction of susceptibility to activity based anorexia in male and female rats (2014) (18)
- Orexin signaling in rostral lateral hypothalamus and nucleus accumbens shell in the control of spontaneous physical activity in high- and low-activity rats. (2017) (18)
- Pharmacotherapy for Weight Management in the VHA (2017) (18)
- Reduction of high-fat diet-induced obesity after chronic administration of brain-derived neurotrophic factor in the hypothalamic ventromedial nucleus (2011) (18)
- Role of orexin-A in the ventrolateral preoptic area on components of total energy expenditure (2017) (18)
- Impact of retinoic acid exposure on midfacial shape variation and manifestation of holoprosencephaly in Twsg1 mutant mice (2014) (18)
- Effect of peripheral 2-DG on opioid and neuropeptide Y gene expression (1998) (17)
- Buprenorphine increases intake of freely available and operant-contingent food in satiated rats (1995) (17)
- BAT thermogenic activity and capacity are reduced during lactation in ground squirrels. (1993) (16)
- Insulin and metabolic efficiency in rats. I. Effects of sucrose feeding and BAT axotomy. (1986) (16)
- Use of a caspase multiplexing assay to determine apoptosis in a hypothalamic cell model. (2014) (16)
- Food deprivation-induced vs. drug-induced feeding: a behavioral evaluation. (1991) (16)
- The molecular and cellular basis of variable craniofacial phenotypes and their genetic rescue in Twisted gastrulation mutant mice. (2011) (16)
- Intrasubject reproducibility of growth hormone-releasing hormone-stimulated growth hormone in older women, older men, and younger men (1993) (16)
- Maternal diet supplementation with methyl donors and increased parity affect the incidence of craniofacial defects in the offspring of twisted gastrulation mutant mice. (2013) (16)
- Effects of streptozotocin-induced diabetes on feeding stimulated by centrally administered opioid agonists. (1989) (14)
- Naloxone administration following operant training of sucrose/water discrimination in the rat (1997) (13)
- Glycosylation of Twisted Gastrulation is Required for BMP Binding and Activity during Craniofacial Development (2011) (13)
- Effects of methadone on free feeding in satiated rats (1992) (12)
- Cold-induced alterations in uncoupling protein and its mRNA are seasonally dependent in ground squirrels. (1995) (12)
- Interrelationships between calcitonin and other modulators of feeding behavior. (1984) (12)
- The effect of [Phe1ψ(CH2-NH)Gly2]-nociceptin(1-13)NH2 on feeding and c-Fos immunoreactivity in selected brain sites (2000) (11)
- The Function of Twisted Gastrulation in Regulating Osteoclast Differentiation is Dependent on BMP Binding (2015) (11)
- Cartilage proteoglycan release assay. (2001) (11)
- Naloxone induced suppression of feeding in tigers (1985) (11)
- Peptides in regulation of energy metabolism and body weight. (1996) (11)
- Identification and characterization of the glucagon receptor from adipose tissue (1994) (10)
- Erratum to “Weight and body mass index in Parkinson's disease patients after deep brain stimulation surgery” [Parkinsonism and Related Disorders 11 (2005) 247–252] (2006) (10)
- The Challenge of Obesity Management in Primary Care (2000) (10)
- A “NEAT” Approach to Obesity Prevention in the Modern Work Environment (2018) (9)
- Toxoplasma gondii: metabolism of intracellular tachyzoites is affected by host cell ATP production. (1997) (9)
- Appetite regulation: Shedding new light on obesity (1996) (9)
- The adenosine agonist N 6-R-phenylisopropyladenosine (R-PIA) stimulates feeding in rats (1989) (9)
- Insulin, 2-deoxy-D-glucose, and food deprivation as discriminative stimuli in rats (1994) (8)
- Insulin and metabolic efficiency in rats. II. Effects of NE and cold exposure. (1986) (8)
- Vagal Nerve Block for Improvements in Glycemic Control in Obese Patients with Type 2 Diabetes Mellitus: Three-Year Results of the VBLOC DM2 Study (2016) (8)
- It's time to start treating obesity. (2002) (7)
- Role of carbohydrate type on diet selection in neuropeptide Y-stimulated rats. (1997) (7)
- Effects of the opiate antagonists diprenorphine and naloxone and of selected opiate agonists on feeding behavior in guinea pigs. (1990) (7)
- Discriminative stimulus effects of morphine: central versus peripheral training (1999) (6)
- Intrahypothalamic Discriminative Stimulus Effects of Neuropeptide Y (1998) (6)
- Obesity: Progress through genetic manipulation (1998) (6)
- The effect of [Phe(1)psi(CH(2)-NH)Gly(2)]-nociceptin(1-13)NH(2) on feeding and c-Fos immunoreactivity in selected brain sites. (2000) (5)
- Obesity: its time has come. (2002) (5)
- Neuropeptidergic regulation of food intake (1984) (4)
- Methadone and feeding: Sources of differences between home cage and operant chamber assessment procedures (1994) (4)
- Effect of Housing Types on Growth, Feeding, Physical Activity, and Anxiety-Like Behavior in Male Sprague-Dawley Rats (2016) (4)
- Serum FABP4 concentrations decrease after Roux‐en‐Y gastric bypass but not after intensive medical management (2019) (4)
- Stress, peptides, and regulation of ingestive behavior. (1991) (4)
- STZ-induced diabetes decreases and insulin normalizes POMC mRNA in arcuate nucleus and pituitary in rats. (1999) (4)
- Beta-funaltrexamine (beta-FNA) decreases deprivation and opioid-induced feeding. (1991) (4)
- Stress and Consummatory Behavior (1989) (3)
- Injection of &agr;-MSH, but not &bgr;-endorphin, into the PVN decreases POMC gene expression in the ARC (2002) (3)
- Weight Loss Is Durable with Vagal Nerve Blockade (VBLOC) but Not with Sham: 18-Month Results of the ReCharge Trial (2015) (3)
- Peptides and Brain Pathology (1985) (2)
- Leptin action in the brain: view from the chair (2001) (2)
- PL-316: Vagal blocking improves glycemic control and blood pressure in subjects with type 2 diabetes and hypertension (2010) (2)
- Orexins and Opioids in Feeding Behavior (2006) (2)
- Effects of butorphanol on feeding and neuropeptide Y in the rat (2012) (2)
- Severe hyperammonemia in chimeric antigen receptor T cells recipient—unusual differential diagnosis of encephalopathy syndrome (2021) (2)
- Measurement of sleep apnea during obesity treatment. (2002) (2)
- Opiate feeding systems in guinea pigs (1984) (1)
- manifestation of holoprosencephaly in Twisted gastrulation mutant mice (2014) (1)
- Shedding new light on obesity. Appetite regulation. (1996) (1)
- Rare presentation of FDX2‐related disorder and untargeted global metabolomics findings (2021) (1)
- Drug therapy for treatment of obesity. (1997) (1)
- The brain and the biology of obesity. (2005) (1)
- Exenatide for weight‐loss maintenance in adolescents with severe obesity: A randomized, placebo‐controlled trial (2022) (1)
- Unnecessary Speculation About Glucose and RBCs-Reply (1983) (0)
- Circadian and age-associated differences in feeding and spontaneous physical activity contribute to reduced adiposity in obesity resistant rats (2010) (0)
- alters amygdala dynorphin gene expression Opioid receptor blockade in rat nucleus tractus solitarius (2016) (0)
- Neuroendocrine Control of Peripheral Metabolic Function (2007) (0)
- association with liver and adipose tissue effects -- of FGF21 in insulin-resistant mouse models Acute glucose-lowering and insulin-sensitizing action (2011) (0)
- Naloxone and operant responding for food: Effects of deprivation level (1994) (0)
- Orexin A-induced activity is inversely correlated with body weight gain and may promote weight loss in rats (2008) (0)
- Sequence Independent Phylogenetic Footprinting Analysis Identifies Novel Transcription Regulation for Orexin Receptors (2011) (0)
- Transcriptome changes correlate with phenotypic severity in Twisted gastrulation mutant mice (2009) (0)
- AREGU November 46/5 (1999) (0)
- The Lighter Side of Bdnf 4 5 (2011) (0)
- Elevated spontaneous physical activity and lean mass gain in obesity resistant rats (2008) (0)
- The effect of orexin A on food intake and spontaneous physical activity in the paraventricular nucleus and ventral tegmental area (2010) (0)
- Sustained Weight Loss and Safety At Two Years With Vagal Nerve Block In The Recharge Trial (2015) (0)
- Chapter 155 – Opioids (2013) (0)
- P195: Entero-endocrine effects of Roux-en-Y gastric bypass for morbid obesity (2007) (0)
- Control of food intake. (2006) (0)
- POSTERS (2006) (0)
- Drug discrimination following morphine injection into rat paraventricular nucleus (PVN) (1996) (0)
- WITHDRAWN: A Randomized Trial Comparing Roux-en-Y Gastric Bypass to Intensive Medical Management in Obese Patients with Type 2 Diabetes Mellitus (2012) (0)
- PL-42: Vagal blocking for obesity control (VBLOCTM): Ongoing comparison of weight loss with two generations of an active, implantable medical device (2008) (0)
- P-81: Intermittent vagal blockade with an implantable device improves blood pressure in obese subjects (2009) (0)
- Forraging behaviour in the rat following manipulation of reinforcer palatability, deprivational state, and naltrexone and butorphrenol administrations (1996) (0)
- M1255 Intra-Abdominal Vagal Blocking Reduces Calorie Intake, Enhances Satiation and Reduces Hunger During Significant and Sustained Weight Loss in Obese Subjects (2008) (0)
- Divergence of the feeding and thermogenic pathways influenced by NPY in the hypothalamic PVN of the rat. (1998) (0)
- Neural site of leptin influence on neuropeptide Y signaling pathways altering feeding and uncoupling protein. (1998) (0)
- Effect of glucagon on surgically denervated brown fat (1985) (0)
- The effects of chronic insulin treatment on brown adipose tissue metabolism in normal and streptozotocin-induced diabetic rats (1984) (0)
- M1270 Correlations Between Enhanced Satiety and Reduced Calorie Intake During Intermittent Vagal Block (VBLOC Therapy) to Treat Obesity (2009) (0)
- P193: Differential adipokine response in diabetics and non diabetics following the roux en Y gastric bypass (2007) (0)
- Central Regulation of Feeding: Interplay between Neuroregulators (2005) (0)
- Butorphanol effects on feeding and neuropeptide Y gene expression in the rat (2010) (0)
- Erratum: Insulin, 2-deoxy-D-glucose, and food deprivation as discriminative stimuli in rats (Pharmacol Biochem Behav 47(2) 317-324, 1994) (1994) (0)
- Once-Weekly Exenatide Enhances Weight Loss Maintenance in Adolescents with Severe Obesity: A Randomized, Placebo-Controlled Trial (2021) (0)
- P-72: Intermittent vagal blockade with an implantable device improves glycemic control in obese subjects with type 2 diabetes (2009) (0)
- Appetite dysregulation in CF (2009) (0)
- Function, Nomenclature and Pharmacology International Union of Basic and Clinical Pharmacology. LXXXVI. Orexin Receptor (2015) (0)
- Use of a bio-electronic device comprising of targeted dual neuromodulation of the hepatic and celiac vagal branches demonstrated enhanced glycemic control in a type 2 diabetic rat model as well as in an Alloxan treated swine model (2022) (0)
- Microsoft Word-65654747-file00 (2014) (0)
- 1 Brain Orexins and Energy Balance 1 . 1 Orexin (2012) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Charles John Billington?
Charles John Billington is affiliated with the following schools:
